CA125 Levels as a Prognostic Indicator in Lung Cancer
Author Information
Author(s): Y. Kimura, T. Fujii, K. Hamamoto, N. Miyagawa, M. Kataoka, A. Iio
Primary Institution: Ehime University School of Medicine
Hypothesis
Is CA125 a specific tumor marker for lung adenocarcinoma?
Conclusion
CA125 is a good indicator of disease extent and correlates with the prognosis in lung cancer patients.
Supporting Evidence
- 37.8% of patients with squamous cell cancer had increased CA125 levels.
- 30.0% of patients with adenocarcinoma had increased CA125 levels.
- 60.0% of patients with small cell cancer had increased CA125 levels.
- Patients with increased CA125 levels had significantly shorter survival times.
- Most patients with pleural effusions or ascites showed high CA125 levels.
Takeaway
Doctors can use a blood test for CA125 to help understand how serious lung cancer is and how long a patient might live.
Methodology
Serum CA125 levels were measured using a one-step immunoradiometric assay in patients with lung cancer.
Limitations
The study may not account for all variables affecting CA125 levels, and the sample size is limited to specific patient groups.
Participant Demographics
The study included 95 untreated lung cancer patients, with a median age of 71 years, and a mix of male and female participants.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website